Cargando…
Mortality and use of angiotensin-converting enzyme inhibitors in COVID 19 disease: a systematic review
BACKGROUND: Interest exists concerning the use of angiotensin-converting enzyme inhibitors (ACEis) in patients with COVID-19 disease. OBJECTIVES: The aim of the study was to perform a systematic review on mortality associated to the use of ACEi in patients with COVID-19 disease. METHODS: Search in M...
Autor principal: | Nunes, José Pedro L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665268/ https://www.ncbi.nlm.nih.gov/pubmed/33204892 http://dx.doi.org/10.1097/j.pbj.0000000000000085 |
Ejemplares similares
-
Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers and the risk of COVID-19 infection or severe disease: Systematic review and meta-analysis
por: Caldeira, Daniel, et al.
Publicado: (2020) -
Relating angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers with incidence or mortality of COVID‐19
por: Wong, Martin C.S., et al.
Publicado: (2020) -
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Withdrawal Is Associated with Higher Mortality in Hospitalized Patients with COVID-19
por: Roy-Vallejo, Emilia, et al.
Publicado: (2021) -
Effects of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on COVID-19
por: Li, Xiao-Long, et al.
Publicado: (2021) -
Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)